These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10994092)

  • 21. The 'bear trap': the colliding epidemics of tuberculosis and HIV in Russia.
    Drobniewski FA; Atun R; Fedorin I; Bikov A; Coker R
    Int J STD AIDS; 2004 Oct; 15(10):641-6. PubMed ID: 15479497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program.
    Månsson AS; Moestrup T; Nordenfelt E; Widell A
    Scand J Infect Dis; 2000; 32(3):253-8. PubMed ID: 10879594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An analysis of the situation with injection narcotic usage in the city of Voronezh during the development of the HIV infection epidemic in Russia].
    Blinova O; Alekseenko N; Patokin S; Gaĭvoronskaia N; Glushich L; Zemlianskaia N
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (4):40-4. PubMed ID: 10994103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia.
    Rhodes T; Lowndes C; Judd A; Mikhailova LA; Sarang A; Rylkov A; Tichonov M; Lewis K; Ulyanova N; Alpatova T; Karavashkin V; Khutorskoy M; Hickman M; Parry JV; Renton A
    AIDS; 2002 Sep; 16(13):F25-31. PubMed ID: 12218407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam.
    Van Ameijden EJ; Van den Hoek JA; Mientjes GH; Coutinho RA
    Eur J Epidemiol; 1993 May; 9(3):255-62. PubMed ID: 8405310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The monitoring of the spread of drug abuse as an element in the epidemiological surveillance of socially significant infections].
    Luzin PM; Fel'dblium IV; Krasnikova LA; Ostashova VL; Vaĭzin RI
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (4):29-31. PubMed ID: 10994098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Who: four ways to reduce hepatitis infections in people who inject drugs.
    Cent Eur J Public Health; 2012 Sep; 20(3):207. PubMed ID: 23285521
    [No Abstract]   [Full Text] [Related]  

  • 28. [Topical problems in the provision of the Russian Federation's population with sanitary-and-epidemiological well-being].
    Onishchenko GG
    Gig Sanit; 2008; (2):4-15. PubMed ID: 18507165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [World's most rapidly growing HIV epidemic is in Russia. The Russian reporting on HIV infections seems to be reliable].
    Arhem K; Giesecke J
    Lakartidningen; 2002 Oct; 99(43):4268-70. PubMed ID: 12448314
    [No Abstract]   [Full Text] [Related]  

  • 30. [Transfusion safety].
    Aprili G
    Haematologica; 1991 Jun; 76 Suppl 3():385-94. PubMed ID: 1752537
    [No Abstract]   [Full Text] [Related]  

  • 31. The Policy-Driven HIV Epidemic Among Opioid Users in the Russian Federation.
    Heimer R
    Curr HIV/AIDS Rep; 2018 Jun; 15(3):259-265. PubMed ID: 29671203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Country on the verge of an AIDS epidemic. Russia, education (health).
    Sex Wkly Plus; 1997 Jun; ():5. PubMed ID: 12292710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV/AIDS in Russia: determinants of regional prevalence.
    Moran D; Jordaan JA
    Int J Health Geogr; 2007 Jun; 6():22. PubMed ID: 17553136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The priorities in realizing prophylactic programs in a region with a high level of HIV infection].
    Nikitina TN; Natalich IS; Kazmerchuk LG
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (4):74-8. PubMed ID: 10994115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of harm reduction programs on seroincidence of HIV, hepatitis B and C, and syphilis among intravenous drug users in southwest China.
    Ruan Y; Liang S; Zhu J; Li X; Pan SW; Liu Q; Song B; Wang Q; Xing H; Shao Y
    Sex Transm Dis; 2013 Apr; 40(4):323-8. PubMed ID: 23486498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporal trends in the HIV-1 epidemic in Russia: predominance of subtype A.
    Bobkov AF; Kazennova EV; Selimova LM; Khanina TA; Ryabov GS; Bobkova MR; Sukhanova AL; Kravchenko AV; Ladnaya NN; Weber JN; Pokrovsky VV
    J Med Virol; 2004 Oct; 74(2):191-6. PubMed ID: 15332265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The urgent need for HIV and hepatitis prevention in drug treatment programs in Hungary.
    Gyarmathy VA; Rácz J; Neaigus A; Ujhelyi E
    AIDS Educ Prev; 2004 Jun; 16(3):276-87. PubMed ID: 15237056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV and hep. B and C code of practice.
    Aust Nurses J; 1992 Jun; 21(11):25-6. PubMed ID: 1530513
    [No Abstract]   [Full Text] [Related]  

  • 39. [Needlestick injury--risk and prevention of blood borne infections].
    Georgi AK; Ruef C; Rampini SK
    Praxis (Bern 1994); 2009 Oct; 98(20):1119-27, 1129; quiz 1128. PubMed ID: 19809974
    [No Abstract]   [Full Text] [Related]  

  • 40. Absence of viral transmission in injecting drug users in Russia.
    Bobkov AF; Samokhvalov EI; Lvov DK; Bobkova MR; Povkrovsky VV; Weber JN
    Lancet; 2001 Sep; 358(9286):1016-7. PubMed ID: 11586991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.